ECHNO-ICHNO 2023 - 10th European Congress on Head & Neck Oncology
Mar 08 - Mar 11, 2023 | LisbonPortugal
LARVOL is not affiliated with 10th European Congress on Head & Neck Oncology and all trademarks, logos, and brand names are property of their respective owners
Showing 9 abstracts linked to Trials
Predictive value of body composition assessment in R/M SCCHN treated with immunotherapy (NCT04721184)
Exercise prehabilitation in head & neck cancer patients: Preliminary results of the FIT4TREAT trial
Elective neck irradiation guided by sentinel node biopsy in larynx & pharynx cancer: the PRIMO trial
A randomized trial of reduced elective neck radiation dose in head & neck cancer: acute toxicity
InGReS: Intra-treatment Image-Guided Adaptive Radiotherapy Dose-escalation - a Phase 1 study
Diagnostic test accuracy of sentinel lymph node biopsy in larynx & pharynx cancers: a meta-analysis
Net treatment benefit of avasopasem manganese for severe oral mucositis from the ROMAN trial
Neoadjuvant Leukocyte Interleukin Injection (LI) extends locally advanced SCCHN overall survival
Durable response after neoadjuvant immunotherapy in resectable CSCC: The MATISSE trial NCT04620200